Neuregulin-4 is associated with plasma glucose and increased risk of type 2 diabetes mellitus. Swiss Medical Weekly, [S. l.], v. 149, n. 4344, p. w20139, 2019. DOI: 10.4414/smw.2019.20139. Disponível em: https://www.smw.ch/index.php/smw/article/view/2687. Acesso em: 26 oct. 2025.